Eicosanoids in metabolic syndrome.

@article{Hardwick2013EicosanoidsIM,
  title={Eicosanoids in metabolic syndrome.},
  author={James P. Hardwick and Katie Eckman and Yoon Kwang Lee and Mohamed A Abdelmegeed and Andrew R Esterle and William M. Chilian and John Y L Chiang and B J Song},
  journal={Advances in pharmacology},
  year={2013},
  volume={66},
  pages={
          157-266
        }
}
Chronic persistent inflammation plays a significant role in disease pathology of cancer, cardiovascular disease, and metabolic syndrome (MetS). MetS is a constellation of diseases that include obesity, diabetes, hypertension, dyslipidemia, hypertriglyceridemia, and hypercholesterolemia. Nonalcoholic fatty liver disease (NAFLD) is associated with many of the MetS diseases. These metabolic derangements trigger a persistent inflammatory cascade, which includes production of lipid autacoids… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Similar Papers

Loading similar papers…